Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Clarke and Braun’s Six-Step Thematic Analysis Process. by Maria A. Afadapa (22683548)

Subjects:

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Descriptive Statistics of Research Skills and HBV-related Knowledge. by Maria A. Afadapa (22683548)

Subjects:

Demographic and Clinical Characteristics of Study Participants. by Zienab M. Saad (22676502)

Subjects:

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects:

Conceptual framework integrating cultural constructs of PEN-3 model with participatory research strategies—Crowdsourcing, Designathon (Apprenticeship), and PAR—to co-create, implem... by Maria A. Afadapa (22683548)

Subjects:

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Stratification of Liver Stiffness according to eGFR in the MAFLD group. by Zienab M. Saad (22676502)

Subjects:

Overview of the Designathon stages. by Maria A. Afadapa (22683548)

Subjects:

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects:

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. by Bethel Alebel Bayrau (22676588)

Subjects:

Medication-inclusive multivariable logistic regression for MAFLD. by Zienab M. Saad (22676502)

Subjects:

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. by Zienab M. Saad (22676502)

Subjects:

Comparison of Non-invasive Liver Fibrosis Scores. by Zienab M. Saad (22676502)

Subjects:

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. by Zienab M. Saad (22676502)

Subjects:

Proposed pathophysiological crosstalk between MAFLD and CKD. by Zienab M. Saad (22676502)

Subjects:

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects:

Liver Stiffness and Fibrosis Grading by MAFLD Status. by Zienab M. Saad (22676502)

Subjects:

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects: